CTVA Corteva, Inc.
Agricultural Production-Crops · NYSE · SEC CIK 1755672 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY1.0%
TTM net income YoY-52.7%
TTM EPS YoY-51.3%
Revenue 3-yr CAGR0.6%
Net income 3-yr CAGR-6.6%
Margins
Gross margin49.7%
Operating margin—
Net margin4.3%
FCF margin-0.8%
EBITDA margin—
Returns
ROE3.1%
ROA1.8%
ROIC (approx.)—
Asset turnover0.41x
Leverage & solvency
Liabilities / assets42.5%
Debt / equity0.30x
Current ratio1.56x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.56x
Accruals ratio0.8%
Payout ratio63.5%
Capex / revenue3.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $2.46B | $6.38B | $4.91B | $3.91B | $2.62B | $6.46B | $4.42B | $3.98B |
| Cost of revenue | $1.53B | $2.72B | $2.37B | $2.25B | $1.64B | $2.93B | $2.34B | $2.50B |
| Gross profit | $924.00M | $3.66B | $2.53B | $1.66B | $974.00M | $3.52B | $2.08B | $1.48B |
| R&D expense | $397.00M | $388.00M | $341.00M | $413.00M | $351.00M | $375.00M | $335.00M | $365.00M |
| SG&A expense | $732.00M | $1.16B | $877.00M | $860.00M | $725.00M | $1.16B | $751.00M | $735.00M |
| Interest expense | $75.00M | $47.00M | $36.00M | $46.00M | $46.00M | $52.00M | $36.00M | $60.00M |
| Pretax income | -$589.00M | $1.62B | $858.00M | -$530.00M | -$370.00M | $1.80B | $784.00M | $88.00M |
| Income tax | -$62.00M | $408.00M | $133.00M | $7.00M | -$62.00M | $422.00M | $117.00M | $138.00M |
| Net income | -$570.00M | $1.16B | $720.00M | -$552.00M | -$320.00M | $1.31B | $652.00M | -$41.00M |
| EPS (basic) | -0.85 | 1.73 | 1.07 | — | -0.47 | 1.92 | 0.95 | — |
| EPS (diluted) | -0.85 | 1.73 | 1.07 | — | -0.47 | 1.92 | 0.95 | — |
| Dividends declared per share | 0.18 | 0.18 | 0.18 | 0.18 | 0.18 | 0.17 | 0.17 | 0.18 |
| Weighted avg. shares (diluted) | 667.80M | 669.80M | 673.60M | — | 678.70M | 683.10M | 686.60M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $3.93B | $2.37B | $1.96B | $4.52B | $2.51B | $2.06B | $2.01B | $3.11B |
| Short-term investments | $1.00M | $0 | $2.00M | $9.00M | $77.00M | $76.00M | $1.00M | $63.00M |
| Receivables | $4.80B | $5.83B | $7.26B | $4.88B | $5.05B | $5.96B | $6.76B | $4.45B |
| Inventory | $5.48B | $4.44B | $5.20B | $5.67B | $5.31B | $4.32B | $5.13B | $5.43B |
| Current assets | $17.89B | $16.36B | $17.39B | $17.34B | $16.44B | $16.00B | $16.59B | $15.10B |
| PP&E, net | $4.18B | $4.18B | $4.18B | $4.22B | $4.20B | $4.15B | $4.11B | $4.10B |
| Goodwill | $10.42B | $10.44B | $10.41B | $10.46B | $10.51B | $10.52B | $10.33B | $10.41B |
| Intangibles | $7.84B | $8.01B | $8.15B | $8.30B | $8.43B | $8.58B | $8.72B | $8.88B |
| Total assets | $43.03B | $41.64B | $42.72B | $42.84B | $42.20B | $41.76B | $42.12B | $40.83B |
| Current liabilities | $11.45B | $10.79B | $11.85B | $12.12B | $10.42B | $9.52B | $11.48B | $10.39B |
| Short-term debt | $3.99B | $3.19B | $1.67B | $894.00M | $2.69B | $1.94B | $2.29B | $750.00M |
| Long-term debt | $3.46B | $1.68B | $1.68B | $1.69B | $1.69B | $1.69B | $1.79B | $1.95B |
| Total debt | $7.45B | $4.88B | $3.36B | $2.58B | $4.37B | $3.63B | $4.08B | $2.70B |
| Total liabilities | $18.29B | $16.24B | $18.11B | $18.46B | $16.74B | $15.61B | $17.60B | $16.80B |
| Shareholders' equity | $24.49B | $25.16B | $24.36B | $24.14B | $25.22B | $25.91B | $24.29B | $23.79B |
| Net debt | $3.51B | $2.51B | $1.39B | -$1.94B | $1.86B | $1.56B | $2.08B | -$403.00M |
| Shares outstanding | — | — | — | 672.16M | — | 679.88M | 683.03M | 685.60M |
| Cash flow statement | ||||||||
| Operating cash flow | -$591.00M | -$466.00M | -$2.89B | $4.38B | $193.00M | $947.00M | -$2.11B | $4.17B |
| Capital expenditure | $151.00M | $122.00M | $81.00M | $222.00M | $157.00M | $118.00M | $94.00M | $181.00M |
| Free cash flow | -$742.00M | -$588.00M | -$2.97B | $4.15B | $36.00M | $829.00M | -$2.20B | $3.99B |
| Investing cash flow | -$143.00M | -$170.00M | -$77.00M | -$188.00M | -$157.00M | -$164.00M | -$34.00M | -$123.00M |
| Financing cash flow | $2.46B | $1.14B | $389.00M | -$2.20B | $367.00M | -$808.00M | $995.00M | -$3.34B |
| Depreciation & amortization | $306.00M | $339.00M | $297.00M | $306.00M | $300.00M | $301.00M | $296.00M | $302.00M |
| Dividends paid | $120.00M | $120.00M | $121.00M | $121.00M | $122.00M | $116.00M | $116.00M | $118.00M |
| Share buybacks | $0 | $250.00M | $250.00M | $301.00M | $250.00M | $250.00M | $270.00M | $252.00M |
Free plan shows the latest 8 periods; Pro shows all 36 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.